WO2004014318A3 - Compositions de levothyroxine et procedes - Google Patents

Compositions de levothyroxine et procedes Download PDF

Info

Publication number
WO2004014318A3
WO2004014318A3 PCT/US2003/025170 US0325170W WO2004014318A3 WO 2004014318 A3 WO2004014318 A3 WO 2004014318A3 US 0325170 W US0325170 W US 0325170W WO 2004014318 A3 WO2004014318 A3 WO 2004014318A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
compositions
sodium
making
levothyroxine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/025170
Other languages
English (en)
Other versions
WO2004014318A2 (fr
Inventor
Elaine A Strauss
G Andrew Franz
Philip A Dimenna
Rocco L Gemma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
King Pharmaceuticals Inc
Original Assignee
King Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by King Pharmaceuticals Inc filed Critical King Pharmaceuticals Inc
Priority to AU2003268078A priority Critical patent/AU2003268078A1/en
Publication of WO2004014318A2 publication Critical patent/WO2004014318A2/fr
Publication of WO2004014318A3 publication Critical patent/WO2004014318A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne des compositions pharmaceutiques stables ainsi que des procédés de fabrication et d'administration de ces compositions. Dans un mode de réalisation, les compositions pharmaceutiques stabilisées contiennent des principes actifs pharmaceutiques tels que la lévothyroxine (T4) et la liothyronine (T3) sous forme sodée (médicaments hormonaux thyroïdiens), de préférence sous forme d'un solide à libération immédiate. L'invention concerne aussi des procédés de fabrication et d'utilisation de ces compositions stabilisées et à libration immédiate.
PCT/US2003/025170 2002-08-10 2003-08-08 Compositions de levothyroxine et procedes Ceased WO2004014318A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003268078A AU2003268078A1 (en) 2002-08-10 2003-08-08 Levothyroxine compositions and methods

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US40232802P 2002-08-10 2002-08-10
US40238102P 2002-08-10 2002-08-10
US60/402,328 2002-08-10
US60/402,381 2002-08-10
US40357202P 2002-08-14 2002-08-14
US40356902P 2002-08-14 2002-08-14
US40330002P 2002-08-14 2002-08-14
US40354102P 2002-08-14 2002-08-14
US60/403,300 2002-08-14
US60/403,572 2002-08-14
US60/403,541 2002-08-14
US60/403,569 2002-08-14

Publications (2)

Publication Number Publication Date
WO2004014318A2 WO2004014318A2 (fr) 2004-02-19
WO2004014318A3 true WO2004014318A3 (fr) 2004-10-28

Family

ID=31721935

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/025170 Ceased WO2004014318A2 (fr) 2002-08-10 2003-08-08 Compositions de levothyroxine et procedes

Country Status (2)

Country Link
AU (1) AU2003268078A1 (fr)
WO (1) WO2004014318A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1882327A (zh) 2003-11-19 2006-12-20 症变治疗公司 含磷的新的拟甲状腺素药
MX2007014502A (es) 2005-05-26 2008-02-07 Metabasis Therapeutics Inc Tiromimeticos para el tratamiento de enfermedades del higado graso.
JP2020500199A (ja) 2016-11-21 2020-01-09 バイキング・セラピューティクス・インコーポレイテッド グリコーゲン蓄積症の治療方法
AU2018280118B2 (en) 2017-06-05 2021-07-15 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis
ES3053674T3 (en) 2018-03-22 2026-01-23 Viking Therapeutics Inc Crystalline forms and methods of producing crystalline forms of a compound
WO2020117962A1 (fr) 2018-12-05 2020-06-11 Viking Therapeutics, Inc. Compositions pour le traitement de la fibrose et de l'inflammation

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225204A (en) * 1991-11-05 1993-07-06 Chen Jivn Ren Stable dosage of levothyroxine sodium and process of production
US5753254A (en) * 1994-02-01 1998-05-19 Knoll Aktiengesellschaft Therapeutic agents containing thyroid hormones
US5955105A (en) * 1995-11-14 1999-09-21 Knoll Pharmaceutical Company Stabilized thyroid hormone preparations and methods of making same
US6190696B1 (en) * 1998-06-08 2001-02-20 Pieter J. Groenewoud Stabilized thyroxine medications
US6290990B1 (en) * 1994-04-18 2001-09-18 Basf Aktiengesellschaft Slow-release matrix pellets and the production thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225204A (en) * 1991-11-05 1993-07-06 Chen Jivn Ren Stable dosage of levothyroxine sodium and process of production
US5753254A (en) * 1994-02-01 1998-05-19 Knoll Aktiengesellschaft Therapeutic agents containing thyroid hormones
US6290990B1 (en) * 1994-04-18 2001-09-18 Basf Aktiengesellschaft Slow-release matrix pellets and the production thereof
US5955105A (en) * 1995-11-14 1999-09-21 Knoll Pharmaceutical Company Stabilized thyroid hormone preparations and methods of making same
US6190696B1 (en) * 1998-06-08 2001-02-20 Pieter J. Groenewoud Stabilized thyroxine medications

Also Published As

Publication number Publication date
AU2003268078A1 (en) 2004-02-25
AU2003268078A8 (en) 2004-02-25
WO2004014318A2 (fr) 2004-02-19

Similar Documents

Publication Publication Date Title
TW200505498A (en) Sugar-free oral transmucosal solid dosage forms and uses thereof
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
WO2002017918A3 (fr) Formulations a liberation prolongee pour les secretagogues de l'hormone de croissance
BR0003158A (pt) Formulação de dosagem oral de derretimentoinstantâneo
EA017764B8 (ru) Фармацевтическая композиция, способ ее получения и способ лечения вирусных заболеваний с ее использованием
MX2009003030A (es) Forma galenita para la administracion por via transmucosa de principios activos.
WO2002074247A8 (fr) Formulations pharmaceutiques a liberation prolongee
WO2001085257A3 (fr) Compositions d'antagoniste opioide et formes de dosage
PT1412384E (pt) Formulação estável de glp-1 modificado
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
IL165601A0 (en) Oral pharmaceutical forms of liquid drugs having improved bioavailability
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
AU2002231654A1 (en) Pharmaceutical paste comprising an acid-labile active ingredient
MY151468A (en) Controlled release solid preparation
WO2003028624A3 (fr) Compositions de levothyroxine et procedes
IL150528A0 (en) Ibuprofen containing active agent preparation
AP2003002763A0 (en) Controlled release formulations for oral administration
MX2010004556A (es) Formulacion farmaceutica de acido clavulanico.
MXPA03002807A (es) Estabilizacion de formulaciones solidas de farmacos.
WO2002015933A3 (fr) Combinaison
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
WO2003013441A3 (fr) Compositions de levothyroxine et procedes connexes
SI1596841T1 (sl) Terapevtski sistem amoksicilina in klavulanske kisline
WO2004014318A3 (fr) Compositions de levothyroxine et procedes
BR0209155A (pt) Tablete farmacêutico tendo um teor de api elevado

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP